The "Inv16 AML M4Eo Test" is a specialized diagnostic procedure aimed at detecting the inversion 16 (inv(16)) chromosomal abnormality, which is commonly associated with a subtype of Acute Myeloid Leukemia (AML) known as M4Eo. This subtype is characterized by the presence of abnormal eosinophils in the bone marrow. The test plays a crucial role in the diagnosis, prognosis, and management of patients with AML, as the presence of inv(16) is typically associated with a favorable response to certain treatments.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test involves sophisticated techniques to analyze the genetic material of cells from a blood or bone marrow sample. The aim is to identify the specific chromosomal inversion that is indicative of M4Eo AML. Recognizing this genetic marker not only aids in confirming the diagnosis but also assists in tailoring the most effective treatment plan for the patient.
The cost of the Inv16 AML M4Eo Test at DNA Labs UAE is set at 1050 AED. This price reflects the advanced technology and expertise required to accurately detect and interpret the inv(16) chromosomal abnormality. Patients undergoing this test at DNA Labs UAE can expect a high standard of accuracy and reliability, supported by the lab's commitment to using the latest in diagnostic methodologies.
The Venous Thrombosis Risk Analysis Panel Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to assess an individual's risk of developing venous thrombosis. Venous thrombosis, a condition characterized by the formation of blood clots within the veins, can lead to serious complications such as pulmonary embolism if left undetected or untreated. This test analyzes specific genetic markers and other factors that may contribute to the likelihood of clot formation, providing valuable insights into an individual's predisposition to this condition.
Priced at 1290 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and reliability of the results. By evaluating the genetic and molecular components associated with venous thrombosis, the test aids in the early detection and management of the risk, facilitating personalized preventive strategies and interventions. It is an essential tool for individuals with a family history of venous thrombosis or those who exhibit potential risk factors, aiming to enhance healthcare outcomes through precision medicine.
The IGF Binding Protein-1 (IGFBP-1) test is a diagnostic procedure designed to measure the levels of IGFBP-1 in the blood. IGFBP-1 is one of the several proteins that bind insulin-like growth factors (IGFs) which are involved in cellular growth, development, and metabolism. Abnormal levels of IGFBP-1 can indicate various health issues, including growth abnormalities and certain metabolic disorders.
This specific test is available at DNA Labs UAE, a leading laboratory known for its advanced diagnostic services. The cost of the IGFBP-1 test at DNA Labs UAE is 1290 AED. The test is conducted by collecting a blood sample from the patient, which is then analyzed using sophisticated laboratory techniques to determine the concentration of IGFBP-1. This test is crucial for individuals who may be experiencing symptoms related to abnormal growth rates or metabolic issues, as it can provide vital information for diagnosis and treatment planning.
The TBG (Thyroxine Binding Globulin) Test is a specialized blood test designed to measure the levels of TBG in the bloodstream. TBG is a crucial protein that plays a significant role in the transportation and regulation of thyroid hormones, such as thyroxine (T4) and triiodothyronine (T3), throughout the body. These hormones are vital for regulating metabolism, energy generation, and overall physical growth and development.
An imbalance in TBG levels can indicate various thyroid disorders or other health conditions, making this test an important diagnostic tool. High levels of TBG may suggest hypothyroidism, where the thyroid gland is underactive, while low levels could indicate hyperthyroidism, an overactive thyroid.
The TBG Thyroxine Binding Globulin Test is offered at DNA Labs UAE, a state-of-the-art facility known for its precision and reliability in diagnostic services. The test is priced at 1280 AED, reflecting the sophisticated techniques and equipment used to ensure accurate and timely results. Patients opting for this test at DNA Labs UAE can expect professional service and comprehensive support throughout the testing process, from sample collection to the interpretation of results.
The C-KIT Mutation Detection PCR Test is a highly specialized diagnostic procedure aimed at identifying mutations in the C-KIT gene. This gene is crucial because it provides instructions for making a protein that plays a key role in the growth and development of cells. Mutations in the C-KIT gene are associated with a variety of tumors, including gastrointestinal stromal tumors (GISTs), mastocytosis, and certain types of leukemia. Early detection of these mutations can significantly impact the treatment and management of these conditions.
The test utilizes Polymerase Chain Reaction (PCR) technology, a cutting-edge method that amplifies segments of DNA, making it possible to study the genetic material in great detail. This allows for the precise identification of mutations in the C-KIT gene.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the C-KIT Mutation Detection PCR Test is available for 1280 AED. DNA Labs UAE is known for its state-of-the-art technology and expertise in genetic diagnostics, ensuring accurate and reliable test results. This test is a valuable tool for clinicians in the diagnosis and management of diseases associated with C-KIT mutations, facilitating personalized treatment plans for affected individuals.
The Connexin 30 Mutation Detection Test is a specialized genetic test available at DNA Labs UAE, designed to identify mutations in the GJB6 gene, which encodes the connexin 30 protein. This protein plays a crucial role in the formation of gap junctions that facilitate direct cellular communication in various tissues, including the inner ear and skin. Mutations in the GJB6 gene can lead to a range of disorders, most notably hearing impairments and certain skin conditions.
The test is particularly relevant for individuals with a family history of hearing loss or those experiencing symptoms without a clear diagnosis. Early detection through this test can aid in the understanding of the condition's cause, enabling targeted interventions and informed decision-making regarding treatment options. It can also provide essential information for families considering future pregnancies.
Performed at DNA Labs UAE, a facility known for its advanced genetic testing services, the Connexin 30 Mutation Detection Test is priced at 1260 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the GJB6 gene. Results from this test can offer valuable insights into the genetic basis of hearing loss and other related conditions, facilitating a personalized approach to healthcare.
The JAK2 Exon 12 Mutation Detection Test is a specialized diagnostic procedure designed to identify mutations within the exon 12 region of the Janus kinase 2 (JAK2) gene. This test is crucial for the diagnosis and management of certain myeloproliferative neoplasms (MPNs), which are a group of blood cancers characterized by the overproduction of blood cells. Mutations in the JAK2 gene, particularly in the exon 12 region, are associated with a subset of these disorders, including polycythemia vera, essential thrombocythemia, and primary myelofibrosis, especially in cases where the common JAK2 V617F mutation is not present.
Performed at DNA Labs UAE, a leading laboratory known for its advanced genetic testing capabilities, the JAK2 Exon 12 Mutation Detection Test utilizes state-of-the-art technology to provide accurate and reliable results. The test is recommended for individuals showing symptoms of MPNs or those with a known family history of these conditions, to assist in the diagnosis and to guide treatment strategies.
The cost of the JAK2 Exon 12 Mutation Detection Test at DNA Labs UAE is set at 1260 AED. Given the importance of this test in the accurate diagnosis and management of MPNs, it represents a valuable investment in one's health. Patients and healthcare providers can rely on DNA Labs UAE for precise diagnostics, thereby facilitating targeted and effective treatment plans for affected individuals.
The Lysozyme Muramidase Test is a specialized diagnostic procedure aimed at measuring the levels of lysozyme, an enzyme also known as muramidase, in the body. Lysozyme plays a crucial role in the immune system by breaking down the cell walls of certain bacteria, thus contributing to the body's defense against infections. Elevated or decreased levels of this enzyme can indicate various health conditions, including infections, inflammatory diseases, and certain types of leukemia.
The test involves a simple blood sample from the patient, which is then analyzed in a laboratory setting to determine the concentration of lysozyme present. Given its significance in diagnosing and monitoring various medical conditions, the Lysozyme Muramidase Test is an important tool in clinical diagnostics.
At DNA Labs UAE, this test is available for a cost of 1260 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable test results. The facility is committed to providing high-quality diagnostic services, making it a trusted choice for patients and healthcare providers seeking comprehensive health assessments.
The Pernicious Anemia Panel Test is a comprehensive diagnostic tool used to assess the presence of pernicious anemia, a type of vitamin B12 deficiency anemia caused by the body's inability to absorb vitamin B12 due to the lack of intrinsic factor. This condition can lead to various health issues, including fatigue, weakness, memory loss, and neurological changes. The test panel typically includes measurements of vitamin B12 levels, intrinsic factor antibodies, and other related markers to provide a thorough evaluation of the patient's condition.
At DNA Labs UAE, the Pernicious Anemia Panel Test is offered at a cost of 1260 AED. The facility ensures accurate and reliable results, utilizing advanced testing methodologies under the supervision of experienced professionals. This test is crucial for individuals experiencing symptoms of vitamin B12 deficiency or those at risk of pernicious anemia, enabling timely diagnosis and appropriate treatment to prevent complications.
The "5-Fluorouracil (5-FU) Toxicity and Chemotherapeutic Response DPYD Variants Test" is a specialized diagnostic tool offered by DNA Labs UAE, priced at 1260 AED. This test is designed to identify genetic variants in the DPYD gene, which plays a crucial role in the metabolism of 5-FU, a common chemotherapeutic agent used in the treatment of various cancers, including colorectal, breast, and stomach cancers.
5-FU works by inhibiting DNA synthesis in cancer cells, thereby preventing their growth and proliferation. However, its effectiveness and the risk of toxicity vary significantly among individuals, largely due to genetic differences in the DPYD gene. Certain variants in the DPYD gene can lead to reduced or absent activity of the dihydropyrimidine dehydrogenase (DPD) enzyme, which is responsible for breaking down 5-FU. Individuals with these genetic variations may experience severe or life-threatening toxicity when treated with standard doses of 5-FU, including neutropenia, neurotoxicity, severe diarrhea, and mucositis.
The DPYD Variants Test aims to identify patients who are at an increased risk of experiencing adverse reactions to 5-FU chemotherapy. By analyzing specific genetic variants in the DPYD gene, healthcare providers can tailor chemotherapy treatments to the individual's genetic makeup, optimizing therapeutic outcomes while minimizing the risk of toxicity. This personalized approach to cancer treatment enhances the efficacy of 5-FU therapy and improves patient safety.
In summary, the 5-FU Toxicity and Chemotherapeutic Response DPYD Variants Test offered by DNA Labs UAE is a crucial tool in the field of personalized medicine, enabling clinicians to make informed decisions regarding 5-FU chemotherapy regimens based on a patient's genetic predisposition to drug toxicity. At a cost of 1260 AED, this test represents a valuable investment in optimizing cancer treatment and patient care.
